S. H. Subramony

10.9k total citations · 3 hit papers
123 papers, 6.5k citations indexed

About

S. H. Subramony is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, S. H. Subramony has authored 123 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Cellular and Molecular Neuroscience, 83 papers in Molecular Biology and 61 papers in Neurology. Recurrent topics in S. H. Subramony's work include Genetic Neurodegenerative Diseases (89 papers), Mitochondrial Function and Pathology (61 papers) and Neurological disorders and treatments (27 papers). S. H. Subramony is often cited by papers focused on Genetic Neurodegenerative Diseases (89 papers), Mitochondrial Function and Pathology (61 papers) and Neurological disorders and treatments (27 papers). S. H. Subramony collaborates with scholars based in United States, Australia and Canada. S. H. Subramony's co-authors include Tetsuo Ashizawa, Huda Y. Zoghbi, P. J. S. Vig, Chris Amos, William B. Dobyns, Jennifer M. Bailey, David W. Stockton, Olga Zhuchenko, Penelope E. Bonnen and Cheng Chi Lee and has published in prestigious journals such as Neuron, Nature Genetics and Journal of Neuroscience.

In The Last Decade

S. H. Subramony

121 papers receiving 6.3k citations

Hit Papers

Autosomal dominant cerebellar ataxia (SCA6) associated wi... 1997 2026 2006 2016 1997 1997 1997 400 800 1.2k

Peers

S. H. Subramony
Paola Giunti United Kingdom
Stefan M. Pulst United States
Martha Nance United States
Thomas D. Bird United States
Paola Giunti United Kingdom
S. H. Subramony
Citations per year, relative to S. H. Subramony S. H. Subramony (= 1×) peers Paola Giunti

Countries citing papers authored by S. H. Subramony

Since Specialization
Citations

This map shows the geographic impact of S. H. Subramony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. H. Subramony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. H. Subramony more than expected).

Fields of papers citing papers by S. H. Subramony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. H. Subramony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. H. Subramony. The network helps show where S. H. Subramony may publish in the future.

Co-authorship network of co-authors of S. H. Subramony

This figure shows the co-authorship network connecting the top 25 collaborators of S. H. Subramony. A scholar is included among the top collaborators of S. H. Subramony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. H. Subramony. S. H. Subramony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Potashman, Michele, Evan Popoff, Lauren Powell, et al.. (2025). Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology and Therapy. 14(2). 527–545.
2.
Arpin, David J., S. H. Subramony, David E. Vaillancourt, et al.. (2025). Fixel‐Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia. Annals of Clinical and Translational Neurology. 12(9). 1846–1857.
3.
Felice, Kevin J., Per Harald Jonson, J. Sarparanta, et al.. (2024). Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation. Annals of Clinical and Translational Neurology. 11(9). 2392–2405. 1 indexed citations
4.
Subramony, S. H., et al.. (2024). Roussy-Lévy Syndrome: Pes Cavus, Tendon Areflexia, Amyotrophy, Gait Ataxia, and Upper Limb Tremor in a Patient with CMT Neuropathy. Tremor and Other Hyperkinetic Movements. 14(1). 6–6. 1 indexed citations
5.
Rummey, Christian, Susan Perlman, S. H. Subramony, Jennifer Farmer, & David R. Lynch. (2024). Evaluating mFARS in pediatric Friedreich's ataxia: Insights from the FACHILD study. Annals of Clinical and Translational Neurology. 11(5). 1290–1300. 5 indexed citations
6.
Lynch, David R., S. H. Subramony, Kimberly Y. Lin, et al.. (2024). Characterization of Cardiac-Onset Initial Presentation in Friedreich Ataxia. Pediatric Cardiology. 46(2). 379–382. 2 indexed citations
7.
Dilek, Nuran, et al.. (2024). Friedreich Ataxia Caregiver-Reported Health Index. Neurology Clinical Practice. 14(3). e200303–e200303. 1 indexed citations
8.
Dilek, Nuran, Jane Larkindale, David R. Lynch, et al.. (2023). Friedreich's Ataxia-Health Index. Neurology Clinical Practice. 13(5). e200180–e200180. 3 indexed citations
9.
Lynch, David R., Angie Goldsberry, Christian Rummey, et al.. (2023). Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data. Annals of Clinical and Translational Neurology. 11(1). 4–16. 24 indexed citations
10.
Lynch, David R., et al.. (2023). Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort. Journal of Neurology. 271(4). 1844–1849. 2 indexed citations
11.
Lynch, David R., Katherine D. Mathews, Susan Perlman, et al.. (2022). Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia. Journal of Neurology. 270(3). 1615–1623. 10 indexed citations
12.
Lynch, David R., Melanie Chin, Sylvia Boesch, et al.. (2022). Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension. Movement Disorders. 38(2). 313–320. 55 indexed citations
13.
Rummey, Christian, Louise A. Corben, Martin B. Delatycki, et al.. (2022). Natural History of Friedreich Ataxia. Neurology. 99(14). e1499–e1510. 33 indexed citations
14.
Dilek, Nuran, Jane Larkindale, David R. Lynch, et al.. (2022). Patient-Reported Impact of Symptoms in Friedreich Ataxia. Neurology. 100(8). e808–e821. 6 indexed citations
15.
Rummey, Christian, John M. Flynn, Louise A. Corben, et al.. (2021). Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort. Annals of Clinical and Translational Neurology. 8(6). 1239–1250. 17 indexed citations
16.
Lynch, David R., Melanie Chin, Martin B. Delatycki, et al.. (2020). Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Annals of Neurology. 89(2). 212–225. 177 indexed citations
17.
Hastings, Erin, et al.. (2018). Dysphagia in Patients with Friedreich’s Ataxia (P6.342). Neurology. 90(15_supplement). 1 indexed citations
18.
Moscovich, Mariana, Michael S. Okun, Christopher G. Favilla, et al.. (2014). Clinical Evaluation of Eye Movements in Spinocerebellar Ataxias. Journal of Neuro-Ophthalmology. 35(1). 16–21. 46 indexed citations
19.
Paulson, Henry L., Yvon Trottier, John Q. Trojanowski, et al.. (1997). Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3. Neuron. 19(2). 333–344. 692 indexed citations breakdown →
20.
Subramony, S. H., et al.. (1986). Systemic Lupus Erythematosus Presenting with Recurrent Acute Demyelinating Polyneuropathy. European Neurology. 25(6). 397–402. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026